갱년기 장애 시장 규모, 점유율, 성장 분석 : 치료법별, 제품 유형별, 적응증별, 유통상 과제별, 연령층별, 지역별 - 산업 예측(2025-2032년)
Menopause Market Size, Share, and Growth Analysis, By Treatment (Dietary Supplements, OTC Pharma Products), By Product Type (Gel, Injection), By Indication, By Distribution Challenge, By Age Group, By Region - Industry Forecast 2025-2032
세계의 갱년기 장애 시장 규모는 2023년에 186억 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 6.0%로, 2024년 197억 2,000만 달러에서 2032년에는 314억 2,000만 달러로 성장할 전망입니다.
갱년기 시장은 상당수의 여성들이 경험하는 안면홍조, 식은땀, 우울감 등 갱년기 증상을 완화하는 제품에 대한 인식과 수요가 증가하면서 45세에서 55세 사이의 자연적 생물학적 변화로 인해 증상 완화를 위한 건강기능식품, 허브, 시판 의약품에 대한 관심이 급증하고 있습니다. 건강보조식품, 허브 제품, 일반의약품에 대한 관심이 급증했습니다. 인구 고령화, 건강 의식 증가, 자연 및 유기농 솔루션으로의 전환 등이 이러한 성장의 원동력이 되고 있으며, COVID-19 팬데믹은 이러한 추세를 더욱 강화하여 정신건강을 방해하고 여성들이 호르몬 대체요법에 대한 안전한 식물성 대안을 찾고 영양 및 건강 보조 식품의 사용을 증가시키는 결과를 가져왔습니다. 영양 보충제의 사용량을 증가시켰습니다. 이러한 진화하는 환경은 지속적인 시장 확대의 기회를 시사하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
갱년기 장애 시장 규모 : 치료법별 & CAGR(2025-2032)
- 시장 개요
- 식이보충제
- 일반의약품
- 호르몬 제품
- 에스트로겐과 기타 약제 병용
- 에스트로겐과 프로게스틴 병용약
- 에스트로겐 온리 약
- 프로게스틴 온리 약
- 비호르몬 제품
갱년기 장애 시장 규모 : 제품 유형별 & CAGR(2025-2032)
- 시장 개요
- 겔
- 주사
- 경구투여량
- 패치
- 필
- 분말
- 스킨 크림
- 스킨 스프레이(경피)
- 질 크림
- 질링
갱년기 장애 시장 규모 : 적응증별 & CAGR(2025-2032)
- 시장 개요
- 안구건조증
- 건성피부
- 열감(Hot Flashes)
- 심한 감정 변화, 경우울증, 과민성
- 식은땀과 한기
- 골다공증
- 수면장애
- 요절박
- 질 건조
갱년기 장애 시장 규모 : 유통상 과제별 & CAGR(2025-2032)
- 시장 개요
- 병원 약국
- 온라인 스토어
- 소매 약국
갱년기 장애 시장 규모 : 연령층별 & CAGR(2025-2032)
- 시장 개요
- 조기 갱년기 장애
- 초기 갱년기 장애
- 평균 갱년기 장애
- 후기 갱년기 장애
갱년기 장애 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- AbbVie Inc.(USA)
- Astellas Pharma Inc.(Japan)
- Bayer AG(Germany)
- Pfizer Inc.(USA)
- Novartis AG(Switzerland)
- Merck & Co., Inc.(USA)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Eli Lilly and Company(USA)
- GlaxoSmithKline plc(UK)
- Key Developments
- Mithra Pharmaceuticals(Belgium)
- Dr. Reddy's Laboratories Ltd.(India)
- Procter & Gamble(USA)
- Unilever(UK)
- Pure Encapsulations, LLC(USA)
- Rainbow Light(USA)
- Kindra(USA)
- Elektra Health(USA)
결론과 제안
KSA
Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).
The menopause market is on an upward trajectory, reflecting heightened awareness and demand for products that alleviate menopausal symptoms such as hot flashes, night sweats, and mood swings, experienced by a significant percentage of women. Spanning ages 45 to 55, this natural biological transition has prompted a surge in interest for nutritional supplements, herbal products, and over-the-counter medications designed to ease symptoms. Factors fueling this growth include an aging population, increased health consciousness, and a shift toward natural and organic solutions. The COVID-19 pandemic has further intensified these trends, disrupting mental health and prompting women to seek safe, plant-based alternatives to hormone replacement therapy, resulting in a boost in dietary supplement usage. This evolving landscape signals sustained market expansion opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Menopause Market Segments Analysis
Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Menopause Market
The global menopause market is fueled by several key factors, including the aging population, increased awareness, lifestyle changes, and advancements in technology. As life expectancies rise and birth rates decline, more women are entering menopause, creating a substantial demand for menopause-related products and services. For example, the North American Menopause Association reports that about 2 million women in the U.S. go through menopause each year. Additionally, public awareness of menopause symptoms is improving, leading to greater demand for solutions like hormone therapy, herbal supplements, and wellness products. Women are also acknowledging the role of healthy lifestyles in managing menopause symptoms, further driving market growth.
Restraints in the Global Menopause Market
Despite the substantial growth potential in the Global Menopause market, several factors may act as constraints on its expansion. Safety concerns regarding hormone replacement therapy (HRT), particularly its links to increased risks of breast cancer, heart disease, and stroke, are paramount. Consequently, there is a growing demand for non-hormonal alternatives, creating challenges for companies focusing on hormone-based therapies to address these safety issues. Additionally, menopause remains a stigmatized topic in many cultures, leading to a lack of awareness and understanding that can suppress consumer demand and complicate marketing efforts for menopause-related products. Regulatory hurdles impose strict safety and efficacy requirements, further deterring innovation in treatment options. Compounded by insufficient research and development in this field, these factors collectively threaten to hinder the market's advancement.
Market Trends of the Global Menopause Market
The Global Menopause market is witnessing a significant shift towards non-hormonal therapies driven by women's growing apprehension regarding hormone-based treatments and their associated risks. This trend has led to a rising demand for alternative solutions, such as herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based interventions, which are perceived as safer options for managing menopausal symptoms. As awareness around holistic health and wellness increases, healthcare providers and companies are focusing on developing and promoting these non-hormonal alternatives, further shaping the market landscape. This evolution highlights a consumer preference for natural and integrative approaches, signaling a transformative era in menopause management strategies.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Menopause Market Size by Treatment & CAGR (2025-2032)
- Market Overview
- Dietary Supplements
- OTC Pharma Products
- Hormonal products
- Combination Estrogen and Other Medicines
- Combination Estrogen and Progestin Medicines
- Estrogen-Only Medicines
- Progestin-Only Medicines
- Non-hormonal products
Global Menopause Market Size by Product Type & CAGR (2025-2032)
- Market Overview
- Gel
- Injection
- Oral Dosage
- Patch
- Pill
- Powder
- Skin Cream
- Skin Spray (Transdermal)
- Vaginal Cream
- Vaginal Ring
Global Menopause Market Size by Indication & CAGR (2025-2032)
- Market Overview
- Dry Eyes
- Dry Skin
- Hot Flashes
- Mood Swings, Mild depression & Irritability
- Night Sweats and Cold Flashes.
- Osteoporosis
- Trouble Sleeping
- Urinary Urgency
- Vaginal Dryness
Global Menopause Market Size by Distribution Challenge & CAGR (2025-2032)
- Market Overview
- Hospital Pharmacies
- Online Stores
- Retail Pharmacies
Global Menopause Market Size by Age Group & CAGR (2025-2032)
- Market Overview
- Premature Menopause
- Early Menopause
- Average Menopause
- Late Menopause
Global Menopause Market Size & CAGR (2025-2032)
- North America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- Europe (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mithra Pharmaceuticals (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Procter & Gamble (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Unilever (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pure Encapsulations, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rainbow Light (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kindra (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elektra Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
